Editorial
Notes on the morphological features of cotyledonary dissecting leiomyoma, which is rare in clinical practice
Translational Cancer Research
2023;
12
(3)
:452-455
.
(31 March 2023)
Acquired BRAF gene fusions in Osimertinib resistant EGFR-mutant non-small cell lung cancer
Translational Cancer Research
2023;
12
(3)
:456-460
.
(31 March 2023)
Original Article
PAK4-relevant proliferation reduced by cell autophagy via p53/mTOR/p-AKT signaling
Translational Cancer Research
2023;
12
(3)
:461-472
.
(31 March 2023)
Development and validation of nomograms to predict early death in non-small cell lung cancer patients with brain metastasis: a retrospective study in the SEER database
Translational Cancer Research
2023;
12
(3)
:473-489
.
(31 March 2023)
Development and validation of the nomogram based on ultrasound, thyroid stimulating hormone, and inflammatory marker in papillary thyroid carcinoma: a case-control study
Translational Cancer Research
2023;
12
(3)
:490-501
.
(31 March 2023)
Prostate-specific antigen density as the best predictor of low- to intermediate-risk prostate cancer: a cohort study
Translational Cancer Research
2023;
12
(3)
:502-514
.
(31 March 2023)
Clinicopathological analysis of primary thyroid non-Hodgkin lymphoma: a single-center study
Translational Cancer Research
2023;
12
(3)
:515-524
.
(31 March 2023)
Research on the oncogenic role of the house-keeping gene GAPDH in human tumors
Translational Cancer Research
2023;
12
(3)
:525-535
.
(31 March 2023)
An innovative risk index based on neutrophils and macrophages can effectively predict prognosis and immunotherapy response in patients with muscle-invasive bladder cancer
Translational Cancer Research
2023;
12
(3)
:536-549
.
(31 March 2023)
Efficacy and safety of immune checkpoint inhibitors (ICIs) combined with antiangiogenic therapy for thymic epithelial tumors (TETs): a retrospective study
Translational Cancer Research
2023;
12
(3)
:550-557
.
(31 March 2023)
The characteristics of oncological clinical trials investigating the synergistic effect of radiotherapy and immune checkpoint inhibitors: a cross-sectional study
Translational Cancer Research
2023;
12
(3)
:558-571
.
(31 March 2023)
Overexpression of SPHK1 associated with targeted therapy resistance in predicting poor prognosis in renal cell carcinoma
Translational Cancer Research
2023;
12
(3)
:572-584
.
(31 March 2023)
Treatment outcomes of surgery and chemotherapy for pulmonary metastases from non-lung cancers: a propensity score-matched analysis
Translational Cancer Research
2023;
12
(3)
:585-594
.
(31 March 2023)
Comparative analysis of pre- and postmenopausal endometrial cancer in 216 patients
Translational Cancer Research
2023;
12
(3)
:595-604
.
(31 March 2023)
Assessment of the prognostic and clinicopathological significance of HOXA-AS2 in human cancers: a systematic review and meta-analysis
Translational Cancer Research
2023;
12
(3)
:605-615
.
(31 March 2023)
Prognostic significance of thromboembolism in multiple myeloma: a systematic review and meta-analysis
Translational Cancer Research
2023;
12
(3)
:616-623
.
(31 March 2023)
Review Article
Advances in the prediction of spread through air spaces with imaging in lung cancer: a narrative review
Translational Cancer Research
2023;
12
(3)
:624-630
.
(31 March 2023)
The value of analyzing textbook outcomes after laparoscopic hepatectomy—a narrative review
Translational Cancer Research
2023;
12
(3)
:631-637
.
(31 March 2023)
Case Report
Paget disease of the breast with underlying invasive ductal cancer in neurofibromatosis type 1: a case report
Translational Cancer Research
2023;
12
(3)
:638-645
.
(31 March 2023)
Endoscopic treatment of solitary fibrous tumor of the trachea: a case report
Translational Cancer Research
2023;
12
(3)
:646-650
.
(31 March 2023)
B-cell non-Hodgkin lymphoma of the breast in Waldenström’s macroglobulinemia: a case report
Translational Cancer Research
2023;
12
(3)
:651-657
.
(31 March 2023)
Unusual presentation of a neuroendocrine tumor in the ileostomy specimen after rectal cancer treatment: a case report
Translational Cancer Research
2023;
12
(3)
:658-662
.
(31 March 2023)
Intraductal oncocytic papillary neoplasm (IOPN): two case reports and review of the literature
Translational Cancer Research
2023;
12
(3)
:663-672
.
(31 March 2023)
Editorial Commentary
Utility of miRNA biomarkers for detection of early head and neck squamous cell carcinoma
Translational Cancer Research
2023;
12
(3)
:673-675
.
(31 March 2023)
Improved diagnostic accuracy of hybrid positron emission tomography (PET) with tumor-specific radiotracer for head and neck squamous cell carcinoma staging
Translational Cancer Research
2023;
12
(3)
:676-679
.
(31 March 2023)
The benefit of the doubt: PD-L1 status in unresectable stage III NSCLC management
Translational Cancer Research
2023;
12
(3)
:680-683
.
(31 March 2023)
Tumor human papillomavirus: a potential test for cervical cancer prognosis
Translational Cancer Research
2023;
12
(3)
:684-687
.
(31 March 2023)
Efficacy of stereotactic ablative radiotherapy (SABR) during anti-PD-1 in oligoprogressive non-small cell lung cancer and melanoma—a prospective multicenter observational study pointing out new unmet needs
Translational Cancer Research
2023;
12
(3)
:688-691
.
(31 March 2023)
